Annexon Inc (NAS:ANNX)
$ 5.34 0.05 (0.95%) Market Cap: 569.21 Mil Enterprise Value: 258.70 Mil PE Ratio: 0 PB Ratio: 1.70 GF Score: 42/100

Annexon Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 10:15PM GMT
Release Date Price: $4.39 (-5.59%)
Anupam Rama JP Morgan Chase;Co.;Moderator

&-

Welcome everyone, to the 42nd Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad [Ant Grover, Laurea Hall, Malcolm Kuno]. Our next presenting company is Annexon. And presenting on behalf of the company, we have CEO, Douglas Love.

Douglas Love
Annexon Inc - President, Chief Executive Officer, Director

All right. Thank you, Anupam, and thank all of you today. We're delighted to be here to provide an update on Annexon and what promises to be a transformational 2024. This will be the year where we release our first registrational dataset. And just march ever closer towards our mission of helping millions of patients suffering from complement-mediated diseases.

I'll be making forward-looking statements this afternoon and we invite you to look at our materials on file. Annexon is a late-stage clinical company targeting the classical complement pathway to treat a host of different diseases in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot